Four years after Sanofi shelled out $125 million for global rights to Biond Biologic | The company is handing back the tumor ...

William Pao, former Roche R&D leader and Pfizer CDO, now leads Revelio Therapeutics (formerly Launchpad) as CEO, joins ...

The company's molecular research and drug-development platform taps what it calls nature's wisdom to drive the discovery of ...

Novavax on Thursday posted a narrower fourth-quarter loss and said it expects its licensing deal with French drugmaker Sanofi ...

French biotech start-up studio Argobio and non-profit biomedical research center the Institut Pasteur have announced the ...